Please login to the form below

Not currently logged in

Merck buys cancer-killing virus firm Viralytics for $394m

Merck and Co - US headquarters

It will acquire the Australian biotech’s lead cancer therapy Cavatek in the process

AZ adds another Ionis drug in $330m kidney disease deal

Ionis logoThe candidate targets a genetically associated form of the condition

After Axovant shock, Roivant pens diabetes deal with Poxel

Acquires Merck Serono’s diabetes candidate imeglimin as part of the deal

Gilead’s triple HIV drug approval prompts GSK lawsuit

ViiV HealthcareViiV claims bictegravir infringes its patent estate

J&J takes option on Theravance’s JAK drug in $1bn deal

TD-1473 has potential treating ulcerative colitis, Crohn’s and IBD patients

AZ expects return to growth this year after 2017 decline

AstraZeneca AZ headquarters London UKSoriot says the pharma company is 'turning a corner'

Roche faces biosimilar blitz in 2018

Roche Basel SwitzerlandAnalysts predict copycat competitors will slow the Swiss group’s revenue growth

Amazon's healthcare move takes aim at US costs

AmazonFounder Jeff Bezos says it enters the realm ‘open-eyed’ about its difficulty

Ablynx spurns Novo Nordisk and cuts €3.9bn deal with Sanofi

Sanofi receptionThe offer comes at a 110% premium on the Belgian biopharma’s share price

Business in the USAHealth coverage across state lines

Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad

  • Ho_Ung_KimStanding out in a crowd

    Celltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars

  • HeadsThe diseased organisation

    Like humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured

Featured jobs

Subscribe to our email news alerts


Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018